Drug intelligence / Profile preview

Xuetie Dingchuan Gao

Development stage: Unknown
Lead developer: Nanjing University of Chinese Medicine
Administration: Topical

Overview

Xuetie Dingchuan Gao is a traditional Chinese medicine (TCM) medicated plaster developed by the Nanjing University of Chinese Medicine for the treatment of chronic persistent bronchial asthma, specifically the 'cold wheezing' pattern. The therapy involves the application of the herbal plaster to specific acupuncture points (acupoint application), allowing for the transdermal absorption of active botanical constituents. This approach aims to stabilize wheezing and alleviate asthma symptoms through the synergistic effects of its multi-ingredient herbal formulation. It has been studied in Phase 2 clinical trials in China to evaluate its efficacy and safety against placebo-like simulants in adult patients.

Beyond the preview

Go deeper on Xuetie Dingchuan Gao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xuetie Dingchuan Gao.

Explore the full profile